Mount Sinai Beth Israel
Recent News About Mount Sinai Beth Israel
-
Exercise improves mental well-being in women with chronic pelvic pain
A recent study by Mount Sinai researchers indicates that physical activity can enhance mental health in women with chronic pelvic pain disorders (CPPDs) such as endometriosis and uterine fibroids.
-
Mount Sinai-led study reveals key factors in age-related eye gland dysfunction
A research team led by Mount Sinai has made significant progress in understanding the mechanisms behind age-related degeneration in glands essential for eye function.
-
Mount Sinai develops tool to predict synergistic drug combinations
Researchers at the Icahn School of Medicine at Mount Sinai have developed a computational tool named iDOMO to enhance the prediction of drug synergy and facilitate the creation of combination therapies for complex diseases.
-
Researchers find hidden genetic factors in congenital heart disease
Scientists at the Icahn School of Medicine at Mount Sinai, in collaboration with other researchers, have discovered new genetic interactions that may play a role in congenital heart disease (CHD).
-
Study finds treadmill performance key in assessing patient mortality risk
People who can exercise adequately on a treadmill during cardiac stress testing have a reduced mortality risk, irrespective of their heart disease level, according to research led by Mount Sinai.
-
Sotagliflozin reduces heart attacks and strokes in high-risk patients
Sotagliflozin, a medication recently approved by the Food and Drug Administration, has shown significant potential in reducing heart attacks and strokes among patients with type 2 diabetes and kidney disease who also have additional cardiovascular...
-
Mount Sinai experts publish landmark study on eczema in The Lancet
A comprehensive review on atopic dermatitis, commonly known as eczema, has been published in The Lancet by a team of experts led by Dr. Emma Guttman-Yassky from Mount Sinai.
-
Mount Sinai-led study questions efficacy of immune checkpoint inhibitors for hospitalized cancer patients
Researchers from the Icahn School of Medicine at Mount Sinai have reported that immune checkpoint inhibitors (ICIs), a significant type of cancer immunotherapy, are not particularly effective for hospitalized cancer patients.